This page contains information about Novo Nordisk products.

 

Norditropin NordiFlex®

A smooth experience means continually developing devices that are easy to use

Norditropin NordiFlex® — simplicity by design

Easy to use

The Norditropin NordiFlex® 30 mg/3 mL pen is prefilled with medication and has an easy-to-use dosing dial. Norditropin® NordiFlex® 30 mg/3 mL pens require up to 42% less injection force than the previous NordiFlex 5 mg/1.5 mL, 10 mg/1.5 mL, and 15 mg/1.5 mL pens.1, 2 Quick setup and administration make using Norditropin NordiFlex® 30 mg/3 mL pens easy to teach.3,*

Learn more

Norditropin NordiFlex<sup>®</sup> prefilled growth hormone pens

Learn more

*All Norditropin® products must be refrigerated prior to first use. Do not freeze. After initial use, FlexPro® 5 mg/1.5 mL and 10 mg/1.5 mL delivery pens can either be stored outside of the refrigerator (at up to 77°F) for use within 3 weeks, or in the refrigerator (between 36°F and 46°F) for use within 4 weeks. The FlexPro® 15 mg/1.5 mL and NordiFlex® 30 mg/3 mL delivery pens must always be refrigerated (between 36°F and 46°F)—both prior to and after the initial injection—for use within 4 weeks.

The Norditropin® Device Pledge

Norditropin<sup>®</sup> device pledge

If, after filling three paid prescriptions for Norditropin®, your patient is not satisfied with his or her pen, Novo Nordisk will pay up to $125 of the patient’s first copay for a competing medication.

Norditropin® Device Pledge Terms and Conditions
Patients must be new to therapy with Norditropin®, but could have previously taken a competing product. Patients receiving copay assistance with NordiSure are eligible. Patients must provide proof of three paid months of therapy with Norditropin® in compliance with their treatment plan, proof of purchase of a competing product, and a letter stating the reason why they are dissatisfied. Offer expires 60 days after the date of the last script filled by a pharmacy. Patients cannot be receiving copay assistance or a free product from the manufacturer of a competing product. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is not valid for individuals who are covered by Medicaid or Medicare and in certain states. Not valid for residents of Massachusetts. Offer good only in the United States.

References

  1. Data on file. Injection force dynamics at constant injection button speed conditions for present and improved version of Norditropin NordiFlex®, 10 mg. Princeton, NJ: Novo Nordisk Inc; 2008.
  2. Data on file. Injection force dynamics at three injection button speed conditions for present and improved version of Norditropin NordiFlex®, 10 mg: tests with a G32 needle. Princeton, NJ: Novo Nordisk Inc; 2008.
  3. Data on file. Norditropin NordiFlex® 30 mg/3 mL: Development and comparison to Norditropin NordiFlex® 15 mg/1.5 mL. Princeton, NJ: Novo Nordisk Inc; 2008.
  4. Diglas J, Feinböck C, Winkler F, et al. Reduced pain perception with PenMate, an automatic needle insertion device for use with an insulin pen. Practical Diabetes Int. 1999;16(2):39-41.